Repligen (RGEN) Other Accumulated Expenses (2016 - 2025)
Repligen (RGEN) has disclosed Other Accumulated Expenses for 14 consecutive years, with $21.9 million as the latest value for Q1 2025.
- On a quarterly basis, Other Accumulated Expenses rose 14.99% to $21.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was $21.9 million, a 14.99% increase, with the full-year FY2024 number at $15.6 million, down 7.02% from a year prior.
- Other Accumulated Expenses was $21.9 million for Q1 2025 at Repligen, up from $15.6 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $21.9 million in Q1 2025 to a low of $869000.0 in Q3 2021.
- A 5-year average of $15.8 million and a median of $16.3 million in 2023 define the central range for Other Accumulated Expenses.
- Peak YoY movement for Other Accumulated Expenses: soared 1950.98% in 2022, then decreased 7.02% in 2024.
- Repligen's Other Accumulated Expenses stood at $13.7 million in 2021, then increased by 15.8% to $15.9 million in 2022, then increased by 5.78% to $16.8 million in 2023, then fell by 7.02% to $15.6 million in 2024, then skyrocketed by 40.41% to $21.9 million in 2025.
- Per Business Quant, the three most recent readings for RGEN's Other Accumulated Expenses are $21.9 million (Q1 2025), $15.6 million (Q4 2024), and $16.2 million (Q3 2024).